New prostate cancer drug trial aims to control disease with fewer side effects

NCT ID NCT05346848

Summary

This study is testing if a newer drug called darolutamide, when given for 6 months alongside standard radiation therapy, can effectively control prostate cancer. It is being compared to the current standard treatment, which combines radiation with a different type of hormone therapy. The main goal is to see if the new combination can keep PSA levels very low, which is a sign the cancer is under control.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Assitance Publique des Hôpitaux de Marseille - CHU La Timone

    NOT_YET_RECRUITING

    Marseille, 13385, France

    Contact Email: •••••@•••••

  • CHP Saint-Grégoire

    NOT_YET_RECRUITING

    Saint-Grégoire, 35760, France

    Contact Email: •••••@•••••

  • CHRU Besançon

    NOT_YET_RECRUITING

    Besançon, 25030, France

    Contact Email: •••••@•••••

  • CHRU Brest - Hôpital Morvan

    NOT_YET_RECRUITING

    Brest, 29200, France

    Contact Email: •••••@•••••

  • Clinique Pasteur

    NOT_YET_RECRUITING

    Toulouse, 31076, France

    Contact Email: •••••@•••••

  • Hôpital de la Pitié Salpétrière

    NOT_YET_RECRUITING

    Paris, 75651, France

    Contact Email: •••••@•••••

  • IUCT Oncopôle

    NOT_YET_RECRUITING

    Toulouse, 31059, France

    Contact Email: •••••@•••••

  • Institut Bergonie

    RECRUITING

    Bordeaux, 33076, France

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

  • Institut de Cancérologie de l'Ouest - Site René Gauducheau

    NOT_YET_RECRUITING

    Saint-Herblain, 44805, France

    Contact Email: •••••@•••••

  • Sainte Catherine, Institut du Cancer Avignon-Provence

    NOT_YET_RECRUITING

    Avignon, 84918, France

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.